GlassScriptPhysician profile
Erin Henderson
NPI 1063663102
$990.77
in general payments reported to CMS, 2019-2025
17 companies · $530 in 2025
The $530 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.79 · 2023: $14.43 · 2024: $376 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $139.06 | 2025 | Rezdiffra |
| Glaxosmithkline, LLC. | $111.98 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $105.15 | 2019-2025 | Otezla, Repatha, Prolia |
| Astrazeneca Pharmaceuticals LP | $95.55 | 2023-2025 | Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $79.90 | 2025 | Caplyta |
| Abbvie INC. | $73.64 | 2024 | |
| Lilly USA, LLC | $73.34 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $64.29 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Edwards Lifesciences Corporation | $59.69 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Exact Sciences Corporation | $42.02 | 2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $32.98 | 2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $24.52 | 2024 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.88 | 2024 | Ofev |
| Medtronic, INC. | $22.52 | 2024 | Minimed 780g |
| Novartis Pharmaceuticals Corporation | $17.50 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.28 | 2024 | Eliquis |
| Corium, LLC | $10.47 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.